ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain…
Investors and traders are always looking to find fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh analyst research calls to find great…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Broadsoft Inc. (NASDAQ: BSFT) downgraded after poor expense guidance at Mizuho, Oppenheimer, and…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far from Wall St. research calls this Thursday: ADTRAN Inc. (NASDAQ: ADTN) cut to Sell at UBSÂ but raised…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that is…
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Air Products & Chemicals Inc. (NYSE: APD) raised to Buy at Goldman Sachs.…
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from…
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement…
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short…
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short…
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Aetna Inc. (NYSE: AET) Reiterated Buy with a target price of $55…
Markets opened a few ticks lower this morning after a poor report on new claims for unemployment benefits in the US (our coverage here). The report that pending home sales jumped 4.1%…
